• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evidence for Scgb1a1+ Cells in the Generation of p63+ Cells in the Damaged Lung Parenchyma

tetano

Editor, Senior Moderator
Am J Respir Cell Mol Biol. 2013 Oct 17. [Epub ahead of print]
Evidence for Scgb1a1+ Cells in the Generation of p63+ Cells in the Damaged Lung Parenchyma.
Zheng D, Yin L, Chen J.
Source

Singapore-MIT Alliance for Research and Technology, Interdisciplinary Research Group in Infectious Diseases, Singapore, Singapore ; zhengdahai@smart.mit.edu.
Abstract

Transformation related protein 63-expressing (p63+) basal cells are confined to the trachea in the mouse lung. However, after influenza virus infection or bleomycin treatment, patches of p63+ cells were observed in the damaged lung parenchyma. To address whether the newly induced p63+ cells are derived from the p63+ basal cells, we carried out lineage tracing. In keratin 5 (Krt5) promoter-driven CreER system, although pre-existing p63+ basal cells were labeled by EGFP following tamoxifen treatment, none or only a small fraction (~15%) of the p63+ patches were labeled by EGFP following bleomycin treatment or influenza virus infection, respectively. In contrast, most (>60%) of p63+ patches contained EGFP+ cells in Scgb1a1-CreER transgenic system where Clara cells are labeled. Furthermore, many p63+ cells were found in bronchiole-like lumen structures with columnar cells at the lumen side. The columnar cells were positive for Clara cell marker Cyp2f2 and could be traced to the newly induced p63+ cells. These results suggest that most of the newly induced p63+ cells in the damaged parenchyma are likely derived from Clara cells rather than p63+ basal cells and that newly induced p63+ cells may be involved in the regeneration of bronchioles.

PMID:
24134540
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24134540
 
Back
Top Bottom